S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$4.24
+19.1%
$4.51
$3.47
$13.88
$4.96M-1.0811,937 shs120,346 shs
MediWound Ltd. stock logo
MDWD
MediWound
$17.44
-4.6%
$14.84
$7.10
$18.75
$165.51M0.9369,689 shs156,507 shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$6.50
$6.16
$5.06
$9.44
$39.59M0.585,391 shs570 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bon Natural Life Limited stock logo
BON
Bon Natural Life
+17.85%-0.18%-6.76%-18.38%-66.73%
MediWound Ltd. stock logo
MDWD
MediWound
-4.60%+14.14%+10.87%+33.95%+37.65%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.00%-3.27%+13.64%+4.00%-25.29%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/AN/AN/AN/A
MediWound Ltd. stock logo
MDWD
MediWound
1.1431 of 5 stars
3.53.00.00.00.00.80.6
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/A
MediWound Ltd. stock logo
MDWD
MediWound
3.00
Buy$32.0083.49% Upside
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/AN/AN/AN/A

Current Analyst Ratings

Latest MDWD, NAII, and BON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
MediWound Ltd. stock logo
MDWD
MediWound
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$29.52M0.17$5.89 per share0.72$30.65 per share0.14
MediWound Ltd. stock logo
MDWD
MediWound
$18.69M8.86N/AN/A$3.43 per share5.08
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$154.01M0.26$1.08 per share6.04$14.70 per share0.44

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bon Natural Life Limited stock logo
BON
Bon Natural Life
$4.60MN/A0.00N/AN/AN/AN/A5/10/2024 (Estimated)
MediWound Ltd. stock logo
MDWD
MediWound
-$6.72M-$0.77N/AN/AN/A-35.94%-20.22%-10.08%6/4/2024 (Estimated)
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$2.52M-$0.70N/AN/A-3.22%-4.70%-2.77%5/20/2024 (Estimated)

Latest MDWD, NAII, and BON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
MediWound Ltd. stock logo
MDWD
MediWound
-$0.23-$0.19+$0.04-$0.19$5.33 million$5.34 million
2/13/2024Q2 2024
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/A-$0.52-$0.52-$0.52N/A$25.20 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bon Natural Life Limited stock logo
BON
Bon Natural Life
N/AN/AN/AN/AN/A
MediWound Ltd. stock logo
MDWD
MediWound
N/AN/AN/AN/AN/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.03
2.52
2.41
MediWound Ltd. stock logo
MDWD
MediWound
N/A
4.59
4.33
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.11
4.06
2.59

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bon Natural Life Limited stock logo
BON
Bon Natural Life
0.57%
MediWound Ltd. stock logo
MDWD
MediWound
46.83%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
32.40%

Insider Ownership

CompanyInsider Ownership
Bon Natural Life Limited stock logo
BON
Bon Natural Life
26.48%
MediWound Ltd. stock logo
MDWD
MediWound
9.20%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
20.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bon Natural Life Limited stock logo
BON
Bon Natural Life
961.17 million863,000Not Optionable
MediWound Ltd. stock logo
MDWD
MediWound
1009.49 million8.62 millionOptionable
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
3176.09 million4.84 millionNot Optionable

MDWD, NAII, and BON Headlines

SourceHeadline
Natural Alternatives International (NASDAQ:NAII) Coverage Initiated at StockNews.comNatural Alternatives International (NASDAQ:NAII) Coverage Initiated at StockNews.com
americanbankingnews.com - April 16 at 2:22 AM
Natural Alternatives International (NASDAQ:NAII) Research Coverage Started at StockNews.comNatural Alternatives International (NASDAQ:NAII) Research Coverage Started at StockNews.com
americanbankingnews.com - April 8 at 2:26 AM
Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production NeedsNatural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs
globenewswire.com - April 2 at 9:00 AM
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-AlanineCarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine
finance.yahoo.com - February 15 at 1:08 PM
CarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-AlanineCarnoSyn® Brands Partners With Barentz for Exclusive Brazilian Distribution of CarnoSyn® Beta-Alanine
globenewswire.com - February 15 at 11:00 AM
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD ResultsNatural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
markets.businessinsider.com - February 13 at 7:32 PM
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD ResultsNatural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
finance.yahoo.com - February 13 at 7:32 PM
Natural Alternatives International, Inc. Announces 2024 Q2 and YTD ResultsNatural Alternatives International, Inc. Announces 2024 Q2 and YTD Results
globenewswire.com - February 13 at 4:30 PM
Natural Alternatives International Inc NAIINatural Alternatives International Inc NAII
morningstar.com - February 8 at 10:11 PM
Shareholders Will Probably Hold Off On Increasing Natural Alternatives International, Inc.s (NASDAQ:NAII) CEO Compensation For The Time BeingShareholders Will Probably Hold Off On Increasing Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Compensation For The Time Being
finance.yahoo.com - December 1 at 7:51 AM
Returns On Capital At Natural Alternatives International (NASDAQ:NAII) Paint A Concerning PictureReturns On Capital At Natural Alternatives International (NASDAQ:NAII) Paint A Concerning Picture
finance.yahoo.com - November 17 at 10:08 AM
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Natural Alternatives International, Inc. Investors ...ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Natural Alternatives International, Inc. Investors ...
bakersfield.com - September 25 at 5:20 PM
Natural Alternatives International, Inc. Announces 2023 Q4 and YTD ResultsNatural Alternatives International, Inc. Announces 2023 Q4 and YTD Results
finance.yahoo.com - September 21 at 5:11 PM
NAII INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Natural Alternatives International, Inc. Investors With Losses to Inquire About Securities Class Action ...NAII INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Natural Alternatives International, Inc. Investors With Losses to Inquire About Securities Class Action ...
businesswire.com - September 18 at 8:09 PM
Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee FurloughsNatural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs
finance.yahoo.com - August 24 at 2:07 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Natural Alternatives International, Inc. - NAIISHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Natural Alternatives International, Inc. - NAII
benzinga.com - August 21 at 4:05 PM
Natural Alternatives International craters after company temporarily shutters facility, furloughs employeesNatural Alternatives International craters after company temporarily shutters facility, furloughs employees
msn.com - August 16 at 6:37 PM
Natural Alternatives International Appoints New VP of Global SalesNatural Alternatives International Appoints New VP of Global Sales
finance.yahoo.com - July 25 at 10:41 AM
Vyvanse Alternatives: Best Natural OTC Vyvanse Alternatives For ADHD in 2023Vyvanse Alternatives: Best Natural OTC Vyvanse Alternatives For ADHD in 2023
outlookindia.com - July 23 at 7:01 PM
NAI’s manufacturing capacity grows as sales, headcount shrinkNAI’s manufacturing capacity grows as sales, headcount shrink
naturalproductsinsider.com - June 1 at 5:50 PM
SR CarnoSyn® Sustained Release Beta-Alanine Selected as Finalist for Ingredient of the Year in Healthy Aging and Cognitive Function by NutraIngredients-USA Awards 2023SR CarnoSyn® Sustained Release Beta-Alanine Selected as Finalist for Ingredient of the Year in Healthy Aging and Cognitive Function by NutraIngredients-USA Awards 2023
finance.yahoo.com - May 31 at 4:47 PM
Natural Alternatives International Strengthens Capabilities by Adding New U.S. Manufacturing Facility in CaliforniaNatural Alternatives International Strengthens Capabilities by Adding New U.S. Manufacturing Facility in California
finance.yahoo.com - May 24 at 1:10 PM
Researchers Behind Recent Publication on SR CarnoSyn® Beta-Alanine Tablets Ability to Improve Cognitive Health Presenting at American College of Sports Medicine and Exercise Science (ACSM) 2023 Annual MeetingResearchers Behind Recent Publication on SR CarnoSyn® Beta-Alanine Tablet's Ability to Improve Cognitive Health Presenting at American College of Sports Medicine and Exercise Science (ACSM) 2023 Annual Meeting
finance.yahoo.com - May 17 at 3:43 PM
Study: Beta-alanine could help adults with cognitive declineStudy: Beta-alanine could help adults with cognitive decline
naturalproductsinsider.com - May 9 at 1:09 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bon Natural Life logo

Bon Natural Life

NYSE:BON
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. It offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements. Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is based in Xi'an, the People's Republic of China.
MediWound logo

MediWound

NASDAQ:MDWD
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Natural Alternatives International logo

Natural Alternatives International

NASDAQ:NAII
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.